Skip to main content

Advertisement

SpringerLink
Log in

Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Vertebral fractures due to osteoporosis are a common but frequently unrecognized complication in established ankylosing spondylitis (AS). It is known that inflammatory activity in rheumatic diseases (i.e., proinflammatory cytokines) itself plays a possible role in the pathophysiology of bone loss. The aim of this study was to analyze whether inflammatory activity and an alteration of the vitamin D metabolism play a substantial role in the loss of bone mass in AS. In this cross-sectional study, 58 patients with established AS and an age- and sex-matched control group were examined. The vitamin D status was investigated, as was, in parallel, the relationship to disease activity (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], Bath Ankylosing Spondylitis Disease Activity Index [BASDAI]), markers of bone metabolism (parathyroid hormone [PTH], 1.25 vitamin D3, 25 vitamin D3), calcium, bone alkaline phosphatase (bone-AP), urine cross-links, and plasma tumor necrosis factor α(TNFα). Bone mineral density was measured by quantitative computed tomography (QCT) of the lumbar spine. Osteoporosis was diagnosed in early as well as in progressive stages of AS (23/58=39.6%). Furthermore, serum levels of 1.25 vitamin D3 and PTH were negatively correlated with disease activity and TNFα. The excretion of cross-links showed a positive correlation with disease activity and TNFα, and 1.25 vitamin D3 and PTH were positively correlated with bone-AP. TNFα also positively correlated with disease activity. AS patients with osteoporosis showed significantly increased CRP, ESR, cross-links and PTH and a significantly decreased 1.25 D3. Osteoporosis is frequent in AS and high disease activity is associated with an alteration in vitamin D metabolites and increased levels of bone resorption in active AS. Our findings propose a close association of BMD, bone metabolism and inflammatory activity, possibly related to vitamin D inflammation interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Will R, Palmer R, Bhalla AK, Ring F, Colin A (1989) Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 2:1483–1485

    Article  PubMed  Google Scholar 

  2. Bhalla AK, Shenstone B (1992) Bone densitometry measurements in early inflammatory disease. Baillières Clin Rheumatol 2(6):405–414

    Google Scholar 

  3. Gratacós J, Collado A, Pons F, Osaba M, Sanmarti R, Roqué M et al (1999) Significant loss of bone mass in patients with early active ankylosing spondylitis. Arthritis Rheum 42:2319–2324

    Article  PubMed  Google Scholar 

  4. Manolagas SCV (1995) Role of cytokines in bone resorption. Bone 16 [Suppl 1]:63–67

  5. Manolagas SCV (1995) Bone marrow, clastic and blastic cell system: Quo vadis? Calcif Tissue Int 56 [Suppl 1]:2–53

  6. Pacifici R (1995)Cytokines and osteoclast activity. Calcif Tissue Int 56 [Suppl 1]:27–28

  7. Hahn G, Stuhlmueller B, Hain N, Kalden JR, Pfizemaier K, Burmester GR (1993) Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy. J Clin Invest 91:862–870

    PubMed  Google Scholar 

  8. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P (1991) Interleukin-1β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 10:15–21

    PubMed  Google Scholar 

  9. Lange U, Jung O, Teichmann J, Neeck G (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 12:1031–1035

    Article  PubMed  Google Scholar 

  10. Moll LMH, Wright V (1973) New York clinical criteria for ankylosing spondylitis. A statistical evaluation. Ann Rheum Dis 32:354

    PubMed  Google Scholar 

  11. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218–1227

    PubMed  Google Scholar 

  12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisfrod P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    PubMed  Google Scholar 

  13. Payne RB, Carrver ME, Morgan DB (1979) Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual. J Clin Pathol 32:56–60

    PubMed  Google Scholar 

  14. Melton LJ 3rd, Lane AW, Cooper C, Eastell R, O’Fallon WM, Riggs BL (1993) Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113–119

    Article  PubMed  Google Scholar 

  15. Karberg K, Zochling J, Sieper J, Felsenberg D, Braun J (2005) Bone loss is more frequently detected in ankylosing spondylitis patients with syndesmophytes. J Rheumatol 32(7):1290–1298

    PubMed  Google Scholar 

  16. Lange U, Kluge A, Teichmann J, Stracke H, Rau WS, Schmidt KL (2001) Bone density measurement by dual X-ray absorptiometry (DXA) and single energy-quantitative computed tomography (SE-QCT) in ankylosing spondylitis—critical comments. Akt Rheumatol 26:1–6

    Article  Google Scholar 

  17. Lange U, Kluge A., Strunk J, Teichmann J, Bachmann G (2004) Ankylosing spondylitis and bone mineral density—What is the ideal tool for measurement? Rheumatol Int (epub ahead of print; (11)5:S0172–8172)

  18. Ott V (1972) Klinik und Therapie der ankylosierenden Spondylitis (Morbus Strümpell-Marie-Bechterew) In: Brügel H (ed) Fortschritte auf dem Gebiet der rheumatischen Erkrankungen und der degenerativen Gelenkerkrankungen. Schattauer, Stuttgart, pp 92–104

  19. Amento EP (1987) Vitamin D and the immune system. Steroids 49:55–72

    Article  PubMed  Google Scholar 

  20. Overbergh L, Decallonne B, Valckx D et al (1998) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139–146

    Article  Google Scholar 

  21. Obermayer-Pietsch BM, Lange U, Tauber G, Frühauf G, Fahrleitner A, Dobnig H, Hermann J, Aglas F, Teichmann J, Neeck G, Leb G (2003) Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis. Osteoporos Int 14:995–1000

    Article  PubMed  Google Scholar 

  22. Quinn JM, Itoh K, Udagawa N (2001) Transforming growth factor beta affects osteoclast differentiation via direct and indirect interactions. J Bone Miner Res 16:1787–1794

    PubMed  Google Scholar 

  23. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507–511

    PubMed  Google Scholar 

  24. Baeten D, Kruithof E, Van den Bosch F et al (2001) Immunomodulatory effects of anti-tumor necrosis factor alpha therapy on synovium in spondylarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 44:186–195

    Article  PubMed  Google Scholar 

  25. Fernandez-Martin JL, Kurian S, Farmer P et al (1998) Tumor necrosis factor activates a nuclear inhibitor of vitamin D and retinoid -X receptors. Mol Cell Endocrinol 25:65–72

    Article  Google Scholar 

  26. Kuno H, Kurian SM, Hendy GN et al (1994) Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element. Endocrinology 134:2524–2531

    Article  PubMed  Google Scholar 

  27. Schacht E (2000) Osteoporosis in rheumatoid arthritis: significance of alfacalcidol in prevention and therapy. Z Rheumatol 59:10–20

    Article  PubMed  Google Scholar 

  28. Shany S, Levy Y, Lahav-Cohen M (2001) The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression. Steroids 66:319–325

    Article  PubMed  Google Scholar 

  29. Fuss M, Pepersack T, Gillet C, Karmali R, Corvilain J (1992) Calcium and vitamin D metabolism in granulomatous diseases. Clin Rheumatol 11:28–36

    PubMed  Google Scholar 

  30. Wemeau JL (1995) Calciotropic hormones and ageing. Horm Res 43:76–79

    PubMed  Google Scholar 

  31. Bouillon R, Okmamura WH, Norman AW (1995) Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200–257

    Article  PubMed  Google Scholar 

  32. Toussirot E, Ricard-Blum S, Dumoulin G, Cedoz JP, Wendling D (1999) Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology 38:21–27

    Article  PubMed  Google Scholar 

  33. Compston JE, Vedi S, Croucher PI, Garrahan NJ, O Sullivan MM (1994) Bone turnover in non-steroid-treated rheumatoid arthritis. Ann Rheum Dis 53:1263–1266

    Google Scholar 

  34. Ekenstam E (1991) Influence of inflammation and corticosteroid treatment on indices of bone turnover and parathyroid function. Scand J Rheumatol 20:200

    Google Scholar 

  35. Langman CB, Ford, KK, Pachman LM, Glorieux F (1990) Vitamin D metabolism in rats with adjuvant-induced arthritis. J Bone Miner Res 5:905–913

    PubMed  Google Scholar 

  36. Uzawa T, Hori M, Ejiri S, Ozawa H (1995) Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1–34) on rat bone. Bone 16:477–484

    PubMed  Google Scholar 

  37. Teichmann J, Lange U, Stracke H, Doppl W, Klör HU, Federlin K (1997) Rapid trabecular bone loss in female patients with ileitis Crohn and additional sacroiliac joint inflammation. Rheumatol Int 17:45–48

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kerckhoff-Clinic and Foundation, Department of Rheumatology, Clinical Immunology and Osteology, University Gießen, Sprudelhoff 11, 61231, Bad Nauheim, Germany

    U. Lange, J. Strunk, U. Müller-Ladner & K. L. Schmidt

  2. Internal Clinic, Medical Clinic C, Ludwigshafen, Germany

    J. Teichmann

Authors
  1. U. Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Teichmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Strunk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Müller-Ladner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. L. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Lange.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lange, U., Teichmann, J., Strunk, J. et al. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16, 1999–2004 (2005). https://doi.org/10.1007/s00198-005-1990-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-005-1990-5

Keywords

Search

Navigation